OTC · Financial Statements

Primo Nutraceuticals Inc. (BUGVF) Financial Statements

$0.00 OTC: BUGVF Market Cap $26

Primo Nutraceuticals Inc. most recently reported annual revenue of $0, net profit of $-4.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2016201720182019
Revenue———$0
Operating Profit———$-1.0M
Net Profit———$-4.0M
EPS———$-0.88
Op Margin————

Balance Sheet (USD)

Metric2016201720182019
Total Assets$0$0$2.0M$2.0M
Total Liabilities$0$1.0M$2.0M$3.0M
Cash$0$0$0$0
Borrowings$0$0$0$1.0M

Cash Flow (USD)

Metric2016201720182019
Operating Cash Flow$0$0$-1.0M$-1.0M
Investing Cash Flow$0$0$-1.0M$-1.0M
Financing Cash Flow$0$0$1.0M$0
Net Cash Flow$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.50
FCF Yield-3699661.10%
Quick Ratio0.02
Interest Coverage-630.32
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
BUGVF Overview BUGVF Dividend Run Stock Screener